CRBP
Corbus Pharmaceuticals Holding
5.30$
-4.0%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.31 | 0.00 | 0.00 | 0.00 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.03 | 0.03 | 0.05 | 0.07 | 0.02 | 0.01 | 1.28 | 0.01 | – | 0.00 | 0.00 | 0.00 | – | |
| -0.03 | -0.03 | -0.05 | -0.07 | -0.02 | -0.01 | -1.28 | -0.01 | – | 0.00 | 0.00 | 0.00 | – | |
| 1.48 | 1.58 | 2.05 | 2.44 | 0.90 | 0.72 | 1.28 | 1.24 | 1.69 | 1.38 | 1.06 | 1.61 | 4.65 | |
| 0.66 | 0.71 | 1.37 | 1.47 | 0.39 | 0.31 | 0.34 | 0.32 | 0.29 | 0.27 | 0.24 | 0.26 | 0.86 | |
| 2.14 | 2.25 | 3.42 | 3.84 | 1.29 | 1.02 | 0.34 | 1.56 | 1.98 | 1.65 | 1.30 | 1.86 | 5.50 | |
| -2.14 | -2.28 | -3.42 | -3.91 | -1.29 | -1.03 | -1.62 | -1.56 | -1.98 | -1.65 | -1.30 | -1.86 | -5.51 | |
| 0.17 | 0.16 | 0.06 | 0.23 | 0.03 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | – | – | – | |
| -2.27 | -1.81 | -2.45 | -3.55 | -1.15 | -0.78 | -1.39 | -1.44 | -1.90 | -1.54 | -1.23 | -1.81 | -5.25 | |
| 0.19 | 0.00 | 0.00 | – | – | – | – | – | – | – | – | – | – | |
| -2.27 | -1.81 | -2.45 | -3.55 | -1.15 | -0.78 | -1.39 | -1.44 | -1.90 | -1.54 | -1.23 | -1.81 | -5.25 | |
| -2.02 | -1.62 | -2.10 | -3.25 | -1.10 | -0.77 | -1.52 | -1.43 | -1.89 | -1.54 | -1.23 | -1.77 | -5.21 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.